trovafloxacin has been researched along with triazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Muller, CD; Peluso, J; Saab, L; Ubeaud-Sequier, G | 1 |
Ahn, J; Ahn, JH; Cho, HS; Choi, MS; Han, HY; Jegal, H; Kim, S; Oh, JH; Park, SM; Yoon, S | 1 |
2 other study(ies) available for trovafloxacin and triazoles
Article | Year |
---|---|
Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; Chemical and Drug Induced Liver Injury; Flow Cytometry; Fluoroquinolones; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Ketolides; Lipopolysaccharides; Liver; Naphthyridines; Piperazines; Sulfonamides; Triazoles; Tumor Necrosis Factor-alpha; Xenobiotics | 2013 |
TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
Topics: Antimalarials; Autophagy; Cell Survival; Chloroquine; Fluoroquinolones; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Levofloxacin; MAP Kinase Kinase 4; Naphthyridines; Piperazines; Ribosomal Protein S6 Kinases, 70-kDa; Serotonin and Noradrenaline Reuptake Inhibitors; TOR Serine-Threonine Kinases; Triazoles; Tumor Necrosis Factor-alpha | 2021 |